Spontaneous rupture of synovium and tendon

M13_SPONTRUPTSYNOTEND

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M66 Hospital discharge: ICD-9 — 7276 Cause of death: ICD-10 — M66 Cause of death: ICD-9 — 7276 2 out of 7 registries used, show all original rules.	3288
4. Check minimum number of events None	3288
5. Include endpoints None	3288
6. Filter based on genotype QC (FinnGen only)	3288

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M65-M68
Name in latin: Ruptura spontanea membranae synovialis sive tendinis

NAME	M13_SPONTRUPTSYNOTEND
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M66
HD_ICD_9	7276
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M66
COD_ICD_9	7276
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Spontaneous rupture of synovium and tendon based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	20336	10732	9533
Only index persons	19077	10245	8832
Unadjusted period prevalence (%)
Whole population	0.29	0.31	0.27
Only index persons	0.36	0.38	0.34
Median age at first event (years)
Whole population	57.06	60.51	53.09
Only index persons	56.66	60.14	52.61

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3288	1884	1404
Unadjusted period prevalence (%)	0.63	0.64	0.62
Median age at first event (years)	57.38	58.56	55.80

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2941: Matched controls
29420

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M66.0

ICD-10 Finland

Rupture of popliteal cyst

1223.8

323.0

1418

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

8.8

323.0

799

1196

M66.4

ICD-10 Finland

Spontaneous rupture of other tendons

2107.1

323.0

353

M66.5

ICD-10 Finland

Spontaneous rupture of unspecified tendon

524.4

291.8

286

M66.2

ICD-10 Finland

Spontaneous rupture of extensor tendons

1399.4

266.6

256

M79.6

ICD-10 Finland

Pain in limb

4.4

261.0

1266

4344

7276F

ICD-9 Finland

Other disorders of synovium, tendon and bursa, Rupture of tendon, nontraumatic[RUPTURA NONTRAUMATICA TENDINIS ACHILLEI]

+∞

253.8

240

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.2

164.4

732

2149

M66.3

ICD-10 Finland

Spontaneous rupture of flexor tendons

557.5

161.5

159

M17.1

ICD-10 Finland

Other primary gonarthrosis

3.5

152.0

888

3254

NHL30

NOMESCO Finland

Suture or reinsertion of tendon of foot

48.7

136.1

166

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

6.3

135.1

387

688

M01AH05

ATC

etoricoxib; oral

2.6

132.6

1876

11800

N02AX02

ATC

tramadol; systemic, rectal

2.6

127.7

1378

7377

M25.5

ICD-10 Finland

Pain in joint

3.0

127.3

964

4156

9478

FHL

Tendoraphy or reconstruction, e.g., graft, reflex, tenodesis

38.5

122.8

157

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.5

120.3

1458

8234

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

4.0

119.0

541

1571

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

12.2

118.0

222

196

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.9

112.4

525

1555

M19.0

ICD-10 Finland

Primary arthrosis of other joints

4.9

109.7

388

876

N02AJ06

ATC

codeine and paracetamol; systemic

2.5

107.6

1177

6174

N03AX16

ATC

pregabalin; oral

2.9

107.4

783

3229

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

16.3

106.7

176

114

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

4.1

101.2

439

1209

N02BE01

ATC

paracetamol; systemic, rectal

3.0

98.0

2591

20935

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

152.3

97.7

103

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

3.3

96.5

573

2032

H02AB06

ATC

prednisolone; systemic

2.3

96.2

1477

9031

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

9.6

90.4

191

210

SPAT1153

SPAT

Removal of sutures

2.4

90.2

1085

5839

M01AE02

ATC

naproxen; oral, rectal

2.2

89.8

1694

11240

S18

ICPC

Laceration/cut

2.2

88.9

1323

7868

L15

ICPC

Knee symptom/complaint

2.7

86.8

728

3212

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

86.2

942

4800

P01BA02

ATC

hydroxychloroquine; oral

4.0

85.3

377

1047

NDL66

NOMESCO Finland

Transposition of tendon of wrist or hand, other tendon

41.9

83.8

105

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

5.5

83.0

262

515

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.1

82.6

352

944

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.2

81.6

342

903

X59

ICD-10 Finland

Exposure to unspecified factor

2.8

80.5

613

2535

A07EC01

ATC

sulfasalazine; oral, rectal

3.9

80.4

367

1046

M13.9

ICD-10 Finland

Arthritis, unspecified

4.4

80.3

316

785

WX320

NOMESCO Finland

Spinalanesthesy

2.5

79.7

781

3733

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.6

79.6

295

690

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

3.4

79.2

435

1438

A02BC02

ATC

pantoprazole; systemic

2.1

77.9

1946

14152

M01AC06

ATC

meloxicam; systemic, rectal

2.2

76.0

1143

6687

N03AX12

ATC

gabapentin; oral

3.0

73.2

484

1819

M79.0

ICD-10 Finland

Rheumatism, unspecified

22.6

71.8

105

M65.3

ICD-10 Finland

Trigger finger

11.7

71.2

135

120

L17

ICPC

Foot/toe symptom/complaint

2.3

70.9

785

3954

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.4

70.4

273

666

B01AB05

ATC

enoxaparin; parenteral

2.2

69.4

997

5660

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

16.2

69.4

114

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

4.7

69.3

253

581

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

69.1

1342

8630

M70.6

ICD-10 Finland

Trochanteric bursitis

3.2

68.3

398

1366

7276C

ICD-9 Finland

Other disorders of synovium, tendon and bursa, Rupture of tendon, nontraumatic[RUPTURA NONTRAUM TEND FLEX MANUS ET CARPI]

+∞

66.9

TQW40

NOMESCO Finland

Remowal of suture of skin

3.8

66.2

308

886

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

3.8

65.7

300

849

M54.5

ICD-10 Finland

Low back pain

2.1

65.4

912

5082

9477

FHL

Cleansing or splitting of a tendon or tendon sheath (eg tenosynovectomy, tenolysis)

45.0

64.2

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

7.8

64.0

153

206

J01DB01

ATC

cefalexin; oral

2.1

63.9

2359

19204

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

63.8

910

5108

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.0

63.7

411

1509

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

7.4

62.9

156

222

M76.6

ICD-10 Finland

Achilles tendinitis

6.5

62.7

171

278

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.9

62.0

418

1577

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

5.1

61.5

205

426

NBG10

NOMESCO Finland

Acromioplastia

23.8

61.3

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.9

60.8

426

1647

M01AB05

ATC

diclofenac; systemic, rectal

1.9

60.5

1908

14406

M02AA07

ATC

piroxicam; topical

2.0

60.1

1097

6772

L16

ICPC

Ankle symptom/complaint

3.2

59.1

343

1168

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.9

58.3

255

693

M67.4

ICD-10 Finland

Ganglion

6.1

57.9

165

284

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

13.3

57.9

103

M01AH01

ATC

celecoxib; oral (coxibs)

2.4

57.5

577

2730

M01AX17

ATC

nimesulide; oral

2.1

57.1

761

4111

L04AA13

ATC

leflunomide; oral

6.4

56.5

154

250

M48.0

ICD-10 Finland

Spinal stenosis

2.9

56.4

383

1446

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

55.9

372

1386

7276X

ICD-9 Finland

Other disorders of synovium, tendon and bursa, Rupture of tendon, nontraumatic[RUPTURA NONTRAUMATICA TENDINIS ALIA]

+∞

55.4

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

55.0

538

2503

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

14.7

54.7

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

5.8

54.7

161

289

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.8

54.6

401

1589

R60.0

ICD-10 Finland

Localized oedema

2.8

52.8

375

1455

L03

ICPC

Low back symptom/complaint

2.2

52.3

667

3513

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.6

51.5

252

751

X58

ICD-10 Finland

Exposure to other specified factors

2.6

51.3

417

1752

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.0

50.6

216

573

M01AX05

ATC

glucosamine; oral

2.1

49.7

638

3362

WX204

NOMESCO Finland

Axillary plexus blockaced

5.9

49.6

144

254

M79.7

ICD-10 Finland

Fibromyalgia

11.5

49.6

L08

ICPC

Shoulder symptom/complaint

2.3

49.4

536

2612

M79.1

ICD-10 Finland

Myalgia

2.9

49.1

326

1208

J01FF01

ATC

clindamycin; systemic

2.0

48.7

797

4633

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.8

48.0

350

1375

L88

ICPC

Rheumatoid/seropositive arthritis

4.6

47.9

174

395

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

47.8

1087

7108

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

5.6

47.6

145

271

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

47.4

1131

7506

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.0

47.2

158

329

ND1AA

NOMESCO Finland

Wrist X-ray examination

3.5

47.2

233

699

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

3.1

47.1

283

981

M03BX02

ATC

tizanidine; oral

1.8

46.5

1711

13002

SPAT1263

SPAT

Sampling

1.8

46.3

1196

8129

M66.1

ICD-10 Finland

Rupture of synovium

+∞

45.9

M54.4

ICD-10 Finland

Lumbago with sciatica

2.4

45.9

450

2081

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

14.5

45.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

45.6

994

6377

ZXA00

NOMESCO Finland

Right side

1.9

45.1

787

4663

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

5.9

44.7

130

230

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.0

44.3

279

997

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

3.7

44.2

204

578

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.3

44.2

241

779

7276B

ICD-9 Finland

Other disorders of synovium, tendon and bursa, Rupture of tendon, nontraumatic[RUPTURA NONTRAUMATICA TENDINIS EXT MANUS ET CARP]

+∞

43.8

A46

ICD-10 Finland

Erysipelas

2.3

43.2

442

2080

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

43.1

911

5758

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

5.0

43.0

144

300

ZXA05

NOMESCO Finland

Left side

1.9

42.5

742

4384

NDL40

NOMESCO Finland

Repair of tendon of finger with transplant

26.8

42.1

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

30.0

41.8

L28

ICPC

Limited function/disability (L)

2.2

41.2

463

2277

M77.4

ICD-10 Finland

Metatarsalgia

4.4

41.1

154

361

9242

FHL

Other reconstruction or plastic surgery of shoulder joint (including ac joint)

16.4

40.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

40.3

812

5029

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.8

40.2

284

1091

M01AE01

ATC

ibuprofen; systemic, rectal

2.0

39.8

2523

22145

ACC51

NOMESCO Finland

Release of median nerve

3.2

39.7

221

724

9502

FHL

Tendon splitting (De Quervain, click finger)

58.3

39.3

M01AH02

ATC

rofecoxib; oral

2.3

39.3

409

1936

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

6.1

38.8

109

185

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

38.7

493

2557

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

38.4

1092

7523

J01AA02

ATC

doxycycline; systemic

1.7

38.3

2207

18581

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.7

38.3

177

502

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

10.7

38.3

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

7.8

37.9

117

M77.1

ICD-10 Finland

Lateral epicondylitis

3.7

37.9

174

491

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

103.9

37.8

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.3

37.5

394

1873

R06.0

ICD-10 Finland

Dyspnoea

1.9

37.3

666

3934

L14

ICPC

Leg/thigh symptom/complaint

3.0

37.3

233

824

H02AB04

ATC

methylprednisolone; systemic

2.2

37.0

437

2190

M02AA10

ATC

ketoprofen; topical

2.1

36.6

474

2471

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

36.5

402

1950

A02BC05

ATC

esomeprazole; systemic

1.7

36.4

1102

7697

N06AX21

ATC

duloxetine; oral

2.6

36.3

282

1143

J01CA04

ATC

amoxicillin; systemic

1.7

36.3

2195

18550

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.0

36.2

220

767

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

4.2

36.0

143

355

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

5.7

35.7

106

193

L12

ICPC

Hand/finger symptom/complaint

2.3

35.5

366

1720

7276G

ICD-9 Finland

Other disorders of synovium, tendon and bursa, Rupture of tendon, nontraumatic[RUPTURA NONTRAUM TENDINIS ALIA PEDIS ET TARSI]

+∞

35.5

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

35.3

367

1733

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.4

34.8

327

1467

NF1AA

NOMESCO Finland

Hip X-ray examination

2.6

34.8

269

1087

NG2AA

NOMESCO Finland

Patella X-ray examination

4.8

34.4

118

253

L04AB04

ATC

adalimumab; parenteral

7.0

34.1

126

R51.80

ICD-10 Finland

Headache

2.3

34.1

357

1690

N02AA05

ATC

oxycodone; systemic

2.1

33.9

423

2167

L90

ICPC

Osteoarthrosis of knee

2.9

33.6

222

815

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

5.8

33.2

169

TNG10

NOMESCO Finland

Puncture of knee

8.4

33.2

SPAT1211

SPAT

Application of soft bandage

2.5

32.9

268

1116

L04AB01

ATC

etanercept; parenteral

7.7

32.7

102

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

32.6

1002

6966

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

5.8

32.6

165

A02BC03

ATC

lansoprazole; oral

1.7

32.5

797

5190

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

4.5

32.4

119

274

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.1

32.4

131

331

S83.2

ICD-10 Finland

Tear of meniscus, current

2.9

32.3

212

776

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.2

32.2

180

591

J01MA02

ATC

ciprofloxacin; systemic

1.6

32.2

1045

7370

WX200

NOMESCO Finland

Interscalenous plexus blockade

8.4

32.2

SPAT1301

SPAT

No procedures

1.7

32.2

870

5828

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

32.1

239

942

N06AA09

ATC

amitriptyline; systemic

2.5

31.8

269

1140

R52.2

ICD-10 Finland

Other chronic pain

5.1

31.6

103

209

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

31.6

704

4442

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

5.8

31.6

160

R03AC02

ATC

salbutamol; inhalant

1.6

31.5

1360

10318

WX110

NOMESCO Finland

Local anesthesy

1.6

31.4

1818

14829

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

4.3

31.3

120

288

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

6.6

30.9

126

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.0

30.6

191

675

S86.0

ICD-10 Finland

Injury of Achilles tendon

4.5

30.4

112

259

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

30.3

527

3057

J01DA01

ATC

[U] cefalexin; systemic

1.6

30.3

1684

13541

A01

ICPC

Pain general/multiple sites

2.7

29.9

213

820

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

3.5

29.8

143

419

SPAT1312

SPAT

General health counselling

1.7

29.7

842

5691

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

17.0

29.7

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

29.5

467

2618

SPAT1310

SPAT

Counselling related to known health issue

1.7

29.3

853

5806

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.5

29.2

248

1053

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

22.4

29.1

G47.3

ICD-10 Finland

Sleep apnoea

1.8

29.0

574

3473

M01CB01

ATC

sodium aurothiomalate; parenteral

5.9

29.0

141

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.2

29.0

158

510

R42

ICD-10 Finland

Dizziness and giddiness

1.8

28.9

572

3463

UJF32

NOMESCO Finland

Coloscopy

1.7

28.8

691

4444

AA1AD

NOMESCO Finland

CT of head and brain

1.8

28.8

642

4039

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.0

28.7

170

581

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

28.6

808

5446

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

28.3

1317

10078

J01FA06

ATC

roxithromycin; oral

1.6

28.3

1067

7755

SPAT1216

SPAT

Assessment of functional ability

2.0

28.2

429

2366

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

+∞

28.2

L13

ICPC

Hip symptom/complaint

2.0

28.1

415

2263

A02BC01

ATC

omeprazole; systemic

1.7

27.9

729

4797

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.6

27.9

221

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

18.2

27.9

H02AB07

ATC

prednisone; oral

2.0

27.8

404

2187

B01AF01

ATC

rivaroxaban; oral

2.1

27.7

354

1821

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

27.6

1154

8587

NDG30

NOMESCO Finland

Fusion of wrist, total

12.7

27.6

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.4

27.5

245

1067

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

309

536

6.26

172.41

1.8

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

199

213

9.88

168.82

2.2

1.5

59.8

58.5

0.14

148

136

(3000475) Leukocytes [#/volume] in Synovial fluid

279

458

6.56

164.29

2.2

1.6

e6/l

10134.3

13209.4

0.66

224

332

(3021788) Differential panel - Synovial fluid

232

333

7.42

154.79

2.1

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1030

5000

2.54

122.56

2.0

1.7

mg/l

1.2

1.4

0.75

815

3806

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

746

3399

2.54

98.70

1.4

1.2

u/ml

19.0

14.0

0.75

304

1313

(3013707) Erythrocyte sedimentation rate by Westergren method

2520

19186

2.34

91.65

6.7

3.7

mm/h

13.4

13.0

0.74

2384

17596

(3042936) Bacteria identified in Isolate by Culture

724

3357

2.48

91.55

2.6

2.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

127

167

7.87

91.08

2.1

1.4

26.8

30.6

0.48

100

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

756

3634

2.40

87.89

1.4

1.2

iu/ml

41.5

36.6

0.39

265

1181

(3010144) Erythrocytes [#/volume] in Synovial fluid

128

183

7.24

85.28

1.7

1.3

e6/l

123256.1

80456.6

0.26

125

(3044941) Cell count panel - Synovial fluid

157

298

5.48

78.89

1.7

1.4

—

(3006315) Basophils [#/volume] in Blood

1805

12668

1.94

73.61

8.2

5.6

e9/l

0.0

0.19

1657

10813

(3013115) Eosinophils [#/volume] in Blood

1848

13111

1.93

72.51

8.4

5.8

e9/l

0.2

0.09

1697

11346

(3001604) Monocytes [#/volume] in Blood

1794

12609

1.93

72.36

8.2

5.6

e9/l

0.6

0.06

1648

10748

(3026493) Urate [Moles/volume] in Serum or Plasma

1105

6601

2.01

72.02

2.7

umol/l

2710.3

5990.0

2.57

951

5733

(3019198) Lymphocytes [#/volume] in Blood

1827

12964

1.92

71.08

8.2

5.7

e9/l

2.0

1.9

0.30

1695

11263

(3037522) Nuclear Ab [Titer] in Serum

607

2978

2.27

65.36

1.4

1.3

titre

510.8

510.0

0.00

130

625

(3037467) Urinalysis macro (dipstick) panel - Urine

2293

17854

1.94

63.82

5.7

4.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2056

15484

1.87

63.07

5.3

4.6

mmol/l

6.7

0.45

1949

14453

(3013650) Neutrophils [#/volume] in Blood by Automated count

2000

14983

1.85

61.80

10.7

9.4

e9/l

4.2

4.1

0.82

1830

12995

(3006504) Eosinophils/100 leukocytes in Blood

1678

11924

1.83

61.47

8.6

5.8

2.8

0.06

1601

11061

(3019069) Monocytes/100 leukocytes in Blood

1685

11992

1.83

61.39

9.2

6.1

8.6

8.7

1.33

1611

11164

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2538

20570

2.02

61.32

9.7

7.5

u/l

76.7

79.4

2.63

2419

19320

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1441

9780

1.84

61.28

4.6

3.3

ng/l

31.0

56.6

2.31

1086

6828

(3034891) Synovial lining cells/100 cells in Synovial fluid

9.21

60.83

1.9

1.4

2.7

2.8

0.04

(3018010) Neutrophils/100 leukocytes in Blood

1692

12120

1.82

59.73

8.3

5.7

57.7

57.5

0.21

1611

11276

(3002030) Lymphocytes/100 leukocytes in Blood

1709

12312

1.81

58.87

8.8

5.9

27.6

27.5

0.13

1623

11409

(3022096) Basophils/100 leukocytes in Blood

1629

11575

1.81

58.71

8.6

5.9

0.7

0.62

1546

10746

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1685

12176

1.79

56.62

4.6

3.9

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1162

7562

1.83

55.13

2.4

2.0

u/l

194.3

236.5

0.86

1087

7057

(42870588) Differential panel, method unspecified - Blood

1286

8658

1.80

54.29

8.2

5.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3012

26574

2.59

51.75

21.2

13.4

mg/l

20.9

25.2

12.74

2617

20700

(3032080) INR in Blood by Coagulation assay

1505

10714

1.75

51.57

9.3

9.1

inr

1.2

1.3

1.83

451

3023

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1775

13282

1.73

50.43

7.2

6.9

mmol/l

1.2

2.10

1493

11102

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1642

12047

1.72

49.92

6.5

6.0

mmol/l

1.2

1.52

1484

10839

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1186

7948

1.77

49.78

3.1

2.5

u/l

53.6

59.7

5.64

1101

7304

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1493

10720

1.72

48.68

2.5

2.2

nmol/l

78.8

78.6

0.09

1325

9524

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1115

7503

1.74

45.08

3.0

ng/l

1249.8

1532.2

1.62

946

6458

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1791

13796

1.65

42.52

6.4

6.5

umol/l

10.9

11.6

1.74

1701

13076

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

957

6254

1.75

42.43

2.7

2.2

mg/l

3.1

3.0

0.55

839

5262

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1421

10383

1.65

41.08

3.2

2.7

ug/l

140.3

142.0

0.06

1288

9528

(3031040) Bacteria [#/volume] in Urine by Automated count

2110

17073

1.66

40.16

5.6

4.2

e6/l

626.6

2461.6

2.00

256

(3023368) Bacteria identified in Blood by Culture

1041

7054

1.70

39.99

5.2

4.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

401

2019

2.12

39.11

5.3

4.1

0.4

0.1

0.47

123

586

(3035350) Ketones [Presence] in Urine by Test strip

1637

12510

1.61

38.63

4.6

3.5

estimate

0.0

0.50

366

2267

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

140

420

3.44

38.61

2.0

1.6

—

(3019225) pH of Specimen

484

2626

1.99

38.46

4.1

4.4

—

(3017181) Myelocytes/100 leukocytes in Blood

414

2125

2.08

38.34

5.4

4.1

0.9

0.25

127

627

(3002179) Metamyelocytes/100 leukocytes in Blood

388

1948

2.12

38.08

5.0

4.0

0.5

0.6

0.38

450

(40768797) Stomach Pathology biopsy report

581

3387

1.87

37.11

1.3

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

1628

12556

1.59

35.99

6.0

4.7

estimate

0.0

0.50

376

2300

(3022948) Iron [Moles/volume] in Serum or Plasma

646

3930

1.80

35.80

2.7

2.6

umol/l

12.5

13.0

0.66

585

3650

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

570

3340

1.85

35.70

5.1

4.5

33.0

32.6

0.37

409

2182

(3009261) Glucose [Presence] in Urine by Test strip

1643

12716

1.58

35.65

4.8

3.5

estimate

0.0

0.69

365

2242

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

186

697

2.77

34.96

1.7

1.6

iu/ml

0.1

0.2

0.66

134

(3025159) Blasts/100 leukocytes in Blood

372

1907

2.07

34.40

5.5

4.1

0.9

0.4

0.25

108

486

(3021960) Folate [Moles/volume] in Serum or Plasma

894

6025

1.66

34.02

1.6

1.5

nmol/l

21.2

20.8

0.14

735

5086

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

9.21

33.89

1.9

1.3

33.7

34.2

0.03

(3007853) Bacteria identified in Skin by Aerobe culture

487

2766

1.89

33.47

2.1

1.7

—

(3013512) EKG study

1100

7851

1.60

33.01

4.8

3.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

572

3433

1.81

32.90

2.7

2.6

21.8

22.8

0.80

475

2931

(40760892) CBC W Ordered Manual Differential panel - Blood

821

5453

1.67

32.86

6.2

4.5

—

(3029937) Albumin [Presence] in Urine by Test strip

969

6719

1.63

32.70

5.3

3.9

estimate

0.0

0.99

360

2206

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2805

25023

1.82

32.00

6.7

5.6

mmol/mol

40.3

39.9

1.72

2597

22956

(3004789) Transferrin [Mass/volume] in Serum or Plasma

595

3663

1.76

31.24

2.7

2.6

g/l

2.3

0.21

546

3391

(3008898) HLA-B27 [Presence]

159

585

2.80

30.93

1.1

1.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

650

4123

1.72

30.62

2.0

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1286

9648

1.55

30.40

5.0

3.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3054

28127

2.20

30.36

22.0

15.9

mmol/l

4.0

1.72

2987

27324

(3019550) Sodium [Moles/volume] in Serum or Plasma

3047

28041

2.18

30.29

21.8

15.7

mmol/l

139.6

139.7

1.84

2987

27298

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2732

24323

1.73

29.60

5.3

4.6

mu/l

1.9

2.1

1.31

2489

22015

(3024263) Appearance of Synovial fluid

105

5.51

29.58

2.1

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

550

3359

1.77

29.54

24.7

23.8

inr

1.4

1.3

0.94

455

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1407

10840

1.52

29.00

2.1

1.9

pmol/l

96.4

95.3

0.36

761

5548

(3019309) Folate [Moles/volume] in Red Blood Cells

727

4830

1.65

28.50

1.8

1.7

nmol/l

1136.2

1152.4

0.19

548

3596

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2833

25589

1.77

27.77

17.4

12.9

ml/min/173m2

79.2

78.8

0.43

2459

20994

(3044640) Blood type and Crossmatch panel - Blood

1126

8333

1.53

27.65

2.7

2.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

7.35

27.55

1.4

1.2

g/l

42.8

38.2

1.08

(40761511) CBC panel - Blood by Automated count

3024

27928

2.03

26.94

19.8

12.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

173

712

2.51

26.91

2.2

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2310

20015

1.52

25.18

4.4

3.9

pmol/l

14.9

14.8

1.02

2087

18033

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3086

28815

2.15

25.04

14.7

10.1

u/l

26.5

26.2

0.30

2986

27662

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2025

17128

1.47

24.49

3.8

3.0

u/l

52.1

50.5

0.33

1871

15793

(3026008) Bacteria identified in Urine by Culture

1054

7863

1.50

24.16

3.5

3.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

874

6288

1.53

23.72

2.6

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2968

27431

1.84

23.58

5.5

4.9

mmol/l

2.7

2.8

8.93

2714

25090

(3024561) Albumin [Mass/volume] in Serum or Plasma

1449

11550

1.45

23.54

5.1

5.0

g/l

34.9

35.3

2.02

1344

10728

(3005719) IgG [Mass/volume] in Serum or Plasma

330

1843

1.88

23.50

3.3

2.8

g/l

10.0

10.5

1.41

308

1672

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

288

1555

1.93

22.71

3.7

kpa

5.2

0.44

263

1434

(3009343) pH of Capillary blood

285

1535

1.94

22.63

3.7

7.4

0.10

187

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2898

26679

1.73

22.26

5.0

4.3

mmol/l

1.5

1.84

2653

24373

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1200

9313

1.45

22.01

3.9

3.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

315

1771

1.86

21.92

1.9

2.4

—

(3015736) pH of Urine

1240

9690

1.45

21.89

4.3

3.3

—

5.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2912

26870

1.73

21.83

5.1

4.4

mmol/l

4.6

4.7

7.65

2676

24710

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

150

642

2.40

21.45

1.9

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2869

26394

1.68

21.42

5.2

4.5

mmol/l

6.0

1.73

2597

23895

(3007461) Platelets [#/volume] in Blood

3160

29984

2.38

21.32

30.3

20.0

e9/l

255.2

249.7

4.47

3121

29094

(3024731) MCV [Entitic volume]

3161

29998

2.39

21.31

30.1

19.9

91.4

91.2

1.61

3134

29486

(3026361) Erythrocytes [#/volume] in Blood

3161

30001

2.38

21.26

30.2

19.9

e12/l

4.4

4.5

4.29

3111

29001

(3010813) Leukocytes [#/volume] in Blood

3161

30005

2.38

21.18

30.3

20.0

e9/l

6.9

6.7

3.50

3107

29003

(3000963) Hemoglobin [Mass/volume] in Blood

3161

30009

2.38

21.10

30.4

20.0

g/l

133.9

135.2

5.49

3134

29504

(3035941) MCH [Entitic mass]

3160

29997

2.37

21.07

30.1

19.9

30.3

30.4

0.94

3132

29484

(3020630) Protein [Mass/volume] in Serum or Plasma

359

2131

1.77

20.86

2.2

2.7

g/l

66.4

66.3

0.05

322

1936

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2810

25755

1.63

20.82

4.5

3.9

mmol/l

1.3

1.78

2553

23339

(3041096) Erythrocytes [Presence] in Urine by Automated

908

6737

1.48

20.74

4.0

3.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

176

819

2.21

20.71

1.2

u/ml

1.1

1.5

0.16

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

783

5650

1.51

20.47

1.8

1.7

pmol/l

73071300.2

22067471.6

0.84

635

4654

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

464

2975

1.65

20.28

4.2

4.5

u/l

244.9

245.8

0.06

426

2816

(3023520) Reticulocytes [#/volume] in Blood

362

2176

1.75

20.10

3.3

2.7

e9/l

70.1

68.0

0.51

288

1644

(3009015) Lactate [Moles/volume] in Synovial fluid

10.54

20.00

1.6

1.1

mmol/l

5.4

6.1

0.19

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

269

1480

1.89

19.99

3.7

3.6

mmol/l

1.7

1.9

0.40

212

1088

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1774

14971

1.40

19.48

2.8

2.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

454

2926

1.64

19.39

2.8

2.5

1.8

0.17

397

2599

(3000850) Epithelial cells [#/volume] in Urine

742

5348

1.50

19.36

2.8

2.5

e6/l

7.5

5.6

0.37

660

4668

(3036481) Cortisol [Moles/volume] in Serum or Plasma

354

2137

1.74

19.34

2.2

2.3

nmol/l

337.1

381.3

4.44

324

1968

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

700

5011

1.50

18.81

1.3

1.2

u/ml

1.5

2.0

0.63

186

1272

(3000494) Fungus identified in Specimen by Culture

452

2931

1.63

18.80

1.6

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1086

8465

1.42

18.68

4.1

3.9

mg/mmol

11.0

9.2

0.43

697

5269

(3012516) Albumin [Mass/volume] in Urine

1037

8020

1.43

18.62

3.4

3.2

mg/l

645.6

363.3

0.82

681

4952

(3045414) Leukocytes [Presence] in Urine

211

1097

1.99

18.53

1.8

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

313

1863

1.75

17.94

1.8

1.6

—

(3017732) Neutrophils [#/volume] in Blood

292

1709

1.78

17.73

3.3

2.9

e9/l

4.0

4.1

0.39

203

1326

(3021589) Normoblasts [#/volume] in Blood

1423

11689

1.38

17.72

13.1

9.3

e9/l

0.0

0.11

1240

9546

(3017143) Hepatitis C virus Ab [Presence] in Serum

388

2464

1.65

17.48

1.6

—

(3022313) Gas panel - Capillary blood

210

1113

1.95

17.45

3.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

164

797

2.11

17.32

2.0

2.2

ug/l

441.6

1022.3

1.25

153

758

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

119

508

2.39

17.16

4.0

3.5

56.1

58.0

0.92

119

508

(3007164) IgA [Mass/volume] in Serum or Plasma

630

4491

1.50

17.09

1.6

1.5

g/l

2.5

0.13

387

2671

(3037121) Protein [Mass/volume] in Urine

175

876

2.05

17.08

3.0

3.3

g/l

0.4

0.3

0.64

358

(3009508) Creatinine [Moles/volume] in Urine

1059

8324

1.40

16.99

3.4

3.1

mmol/l

7.2

7.5

1.23

884

6974

(3028026) IgM [Mass/volume] in Serum or Plasma

258

1478

1.81

16.82

2.3

2.0

g/l

1.3

1.5

0.52

237

1327

(3019150) Specific gravity of Urine by Refractometry

723

5334

1.46

16.40

5.7

4.0

kg/l

1.0

0.34

827

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

428

2826

1.59

16.40

1.9

1.7

—

(3018418) pH of Serum or Plasma

1010

7913

1.40

16.38

4.5

4.1

7.4

0.37

232

1522

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

435

2886

1.58

16.33

1.5

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

410

2689

1.60

16.15

2.3

2.2

ug/g

145.8

147.6

0.03

307

2126

(40768804) Tissue Pathology biopsy report

1323

10869

1.36

15.91

2.2

2.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

186

987

1.94

15.41

1.5

1.6

u/ml

10.3

12.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

423

2827

1.57

15.34

2.0

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

267

2.81

15.06

1.4

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

179

950

1.93

14.83

3.7

4.0

mmol/l

24.8

24.9

0.11

168

872

(3005322) IgE [Units/volume] in Serum or Plasma

234

1353

1.79

14.78

1.5

1.2

u/ml

174.0

202.8

0.24

216

1234

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

322

2.62

14.69

2.2

2.1

mg/l

22.0

22.4

0.02

(40761535) Cells panel - Urine sediment

331

2119

1.62

14.35

4.8

3.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

259

2.78

14.17

3.8

4.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

185

1008

1.88

14.16

1.5

1.8

u/l

41.0

38.9

0.65

160

887

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

192

1080

1.83

13.30

2.1

ug/l

1.5

2.9

1.25

170

959

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

4.72

13.28

1.4

1.8

mg/l

8.9

10.0

0.33

(3015377) Calcium [Moles/volume] in Serum or Plasma

1116

9120

1.34

13.21

3.1

3.6

mmol/l

2.3

2.4

1.37

955

7919

(3002582) Erythrocytes [#/volume] in Urine

978

7837

1.35

13.19

3.7

3.0

e6/l

55.6

90.9

0.60

798

5947

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

117

556

2.14

13.15

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

177

3.08

13.07

1.2

1.1

—

58.9

—

(3018095) Leukocytes [#/volume] in Urine

1118

9154

1.34

13.01

4.3

3.4

e6/l

87.1

118.7

0.52

854

6403

(3011397) Hemoglobin [Presence] in Urine by Test strip

762

5885

1.38

12.93

4.9

3.5

—

(4024509)

255

2.70

12.91

1.7

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

187

1054

1.82

12.87

2.0

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

175

969

1.85

12.76

1.9

1.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1033

8381

1.34

12.73

3.6

3.2

u/l

32.4

35.4

0.97

979

7954

(3021879) Hepatitis B virus core Ab [Presence] in Serum

259

1613

1.66

12.51

1.3

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

242

1487

1.68

12.30

1.7

1.6

—

(36304419) Bacteria [Presence] in Urine

875

6961

1.35

12.20

3.3

2.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

124

622

2.03

12.11

2.4

3.8

—

(3030467) Casts [#/volume] in Urine by Automated count

901

7210

1.34

12.06

3.5

2.9

e6/l

0.4

0.5

0.34

717

5374

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

125

633

2.01

11.89

1.5

1.8

mg/l

13.0

11.4

0.40

114

593

(4146454)

272

2.57

11.89

3.3

2.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

374

2577

1.51

11.68

2.1

g/l

0.2

0.37

345

2402

(3017354) Segmented neutrophils/100 leukocytes in Blood

252

2.61

11.59

3.2

3.8

57.5

58.6

0.12

153

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

122

619

2.01

11.56

1.6

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

145

786

1.88

11.32

1.5

1.6

titre

172.0

352.6

—

(3045424) Erythrocytes [Presence] in Urine

442

2.18

11.31

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

244

1536

1.64

11.30

2.6

2.3

au/ml

62.2

22.6

—

(3026782) Osmolality of Urine

655

5040

1.37

11.18

3.1

2.6

mosm/kgh2o

545.5

551.4

0.28

566

4293

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

311

2082

1.55

11.09

3.6

2.7

ml/min/173m2

62.7

63.9

0.22

141

816

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

127

664

1.95

11.06

1.8

1.5

g/l

1.2

0.22

122

623

(3004809) Band form neutrophils/100 leukocytes in Blood

420

2.20

11.05

3.3

3.5

1.6

1.5

0.08

322

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

224

1390

1.66

10.98

1.3

1.2

au/ml

53.0

49.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

228

1423

1.65

10.92

1.6

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

138

746

1.89

10.88

1.3

—

(3022145) Colonoscopy Study observation

408

2905

1.46

10.80

1.3

—

(40758558) Short blood count panel - Blood

828

6647

1.33

10.62

8.2

6.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

194

1173

1.69

10.50

1.7

1.6

g/l

1.7

1.6

0.39

162

999

(3012095) Magnesium [Moles/volume] in Serum or Plasma

570

4334

1.38

10.40

3.6

3.5

mmol/l

0.8

0.15

524

4048

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

292

1960

1.54

10.29

3.9

4.0

ng/l

83.9

95.2

1.60

243

1661

(3044927) Protein electrophoresis panel - Urine

238

2.55

10.26

1.1

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

391

2792

1.45

10.17

3.9

3.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

327

2.29

10.01

8.0

7.1

mg/l

11.6

11.8

0.22

307

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

115

606

1.93

9.82

1.6

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

330

2299

1.48

9.73

2.4

2.2

ug/l

6.4

8.9

1.78

280

2010

(3003458) Phosphate [Moles/volume] in Serum or Plasma

463

3436

1.40

9.72

6.5

6.2

mmol/l

1.0

0.06

436

3193

(3022621) pH of Urine by Test strip

249

1641

1.56

9.53

3.4

2.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

152

883

1.76

9.52

3.2

2.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

119

643

1.88

9.44

1.8

1.5

g/l

0.2

0.10

113

601

(3025941) Bacteria identified in Stool by Culture

203

1278

1.63

9.42

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

466

3484

1.39

9.35

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

238

2.46

9.27

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

307

2.27

9.21

1.5

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

314

2.26

9.17

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

308

2.27

9.15

1.5

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

308

2.27

9.15

1.5

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

309

2.26

9.08

1.4

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

103

538

1.94

9.05

2.7

2.5

16.0

16.2

0.21

267

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

436

2.05

8.98

1.3

1.2

u/ml

1.1

5.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

451

2.02

8.90

1.4

1.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

441

3299

1.39

8.80

7.4

7.1

mmol/l

104.1

104.4

0.63

427

3228

(40768443) Skin Pathology biopsy report

185

1159

1.63

8.77

1.2

—

(3016502) Oxygen saturation in Arterial blood

370

2687

1.42

8.76

7.3

8.2

95.3

95.8

0.76

359

2580

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

309

2.23

8.66

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

317

2.20

8.56

1.2

1.3

pmol/l

263.4

283.7

0.29

256

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

108

586

1.87

8.49

1.3

1.2

u/ml

22.1

51.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

142

840

1.72

8.38

2.4

3.6

mg/l

40.3

66.2

0.77

107

666

(3034860) Kappa light chains.free [Mass/volume] in Serum

142

840

1.72

8.38

2.4

3.6

mg/l

50.3

52.1

0.06

111

660

(3014271) Vancomycin [Susceptibility]

123

2.95

8.22

2.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

102

550

1.88

8.19

1.4

1.2

u/ml

3.2

8.0

1.19

(3013637) Mi-2 Ab [Presence] in Serum

4.37

8.14

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

4.37

8.14

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

4.37

8.14

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

4.37

8.14

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

531

1.89

8.08

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

137

813

1.71

8.00

2.3

3.5

ratio

1.2

1.4

0.69

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

101

549

1.87

7.92

1.4

1.2

u/ml

2.9

3.7

0.24

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

626

5022

1.30

7.77

4.6

3.5

ng/l

398.1

646.3

0.46

495

4034

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

364

2.06

7.75

1.5

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

461

1.93

7.72

1.6

1.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

439

3349

1.36

7.72

8.2

6.7

—

(3011985) Renin [Units/volume] in Plasma

338

2.09

7.70

1.2

1.4

mu/l

93.6

34.0

1.24

298

(3018677) aPTT in Platelet poor plasma by Coagulation assay

518

4055

1.33

7.66

2.2

2.0

30.3

29.9

0.70

500

3932

(3028626) Oxygen [Partial pressure] in Capillary blood

100

548

1.85

7.66

3.6

3.0

kpa

8.2

8.0

0.41

507

(3008152) Bicarbonate [Moles/volume] in Arterial blood

240

1656

1.48

7.44

7.3

mmol/l

24.4

24.7

0.63

230

1539

(3014111) Lactate [Moles/volume] in Serum or Plasma

312

2264

1.42

7.41

6.8

7.2

mmol/l

1.4

1.3

0.15

305

2186

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

4.87

7.40

1.0

1.2

mg/l

355.9

153.0

0.22

(3015235) Bicarbonate [Moles/volume] in Capillary blood

111

635

1.77

7.40

3.9

3.2

mmol/l

25.4

24.9

0.64

551

(3021901) Oxygen saturation in Capillary blood

461

1.91

7.40

3.4

2.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

437

3358

1.35

7.32

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

373

2.01

7.27

1.6

—

(4010399)

251

1760

1.46

7.18

1.5

1.4

—

(4034850)

136

832

1.66

7.13

13.8

8.8

—

(3026470) Cobalt [Mass/volume] in Blood

163

2.53

7.08

1.9

2.1

ug/l

3.5

0.03

144

(3002173) Hemoglobin [Mass/volume] in Arterial blood

336

2494

1.39

7.00

7.7

8.6

g/l

122.3

121.3

0.38

325

2395

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

372

2810

1.36

6.95

2.0

1.7

1.6

1.5

2.62

312

2452

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

402

1.94

6.87

1.4

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

401

3072

1.35

6.84

7.0

7.6

kpa

11.7

12.5

2.32

388

2926

(3014051) Protein [Presence] in Urine by Test strip

548

1.79

6.77

2.1

2.2

—

(3003396) Base excess in Arterial blood by calculation

399

3059

1.35

6.77

7.0

7.6

mmol/l

1.0

1.2

0.32

319

2390

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

161

2.50

6.75

1.2

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

322

2.04

6.73

1.2

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

400

3072

1.34

6.71

7.0

7.6

kpa

5.1

0.82

387

2928

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

550

1.79

6.70

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

357

1.98

6.69

1.4

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

119

718

1.68

6.60

3.4

3.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

258

2.15

6.57

1.6

2.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

346

1.99

6.55

1.7

g/l

0.6

0.8

0.85

262

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

305

2256

1.39

6.49

4.5

4.0

mmol/l

1.2

0.36

279

1953

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

200

1370

1.49

6.45

2.0

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

310

2.02

6.28

1.2

1.3

nmol/l

—

(3019060) Gas panel - Arterial blood

244

1749

1.43

6.23

4.6

5.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

156

2.45

6.18

1.2

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

527

1.77

6.17

6.9

6.0

iu/ml

3435.8

3238.1

0.02

(3040151) Glucose [Moles/volume] in Capillary blood

285

2.05

6.16

7.6

28.7

mmol/l

7.7

7.1

0.48

240

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

267

2.08

6.04

1.3

1.4

u/l

31.5

35.2

0.33

222

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

274

2.06

6.03

1.6

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

295

2.02

5.99

1.6

1.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.35

5.99

2.1

1.6

ug/l

0.3

0.5

1.03

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

129

2.57

5.95

1.2

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

549

1.73

5.91

2.7

2.2

g/l

127.1

129.6

0.36

383

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

538

4378

1.27

5.87

3.1

2.6

e6/l

1.0

1.2

1.08

349

2446

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

101

603

1.70

5.87

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

163

1095

1.51

5.81

1.1

—

(40761536) Microorganisms panel - Urine sediment

293

2194

1.37

5.79

4.2

3.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

315

2387

1.35

5.77

4.1

3.7

kpa

5.9

5.8

0.29

307

2321

(3020891) Body temperature

155

1034

1.52

5.71

5.6

4.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

133

2.50

5.61

1.1

nmol/l

1.1

17.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.20

5.59

1.3

1.1

84.3

90.8

0.34

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

215

1540

1.42

5.53

2.1

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

128

2.51

5.53

1.2

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

317

2421

1.34

5.52

7.4

7.7

mmol/l

10.5

10.1

0.25

301

2302

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

377

2954

1.31

5.50

2.7

2.5

umol/l

7.8

8.1

0.10

322

2579

(3011412) CD3 cells [#/volume] in Blood

250

2.06

5.49

2.3

2.4

e9/l

1.2

1.0

0.51

157

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

153

2.37

5.47

1.7

1.3

u/ml

1.1

0.6

0.31

(36660697) Celiac disease serology panel - Serum

246

1812

1.39

5.39

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1003

8796

1.20

5.36

5.0

4.8

ug/l

2.1

3.0

3.98

892

7862

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

167

1148

1.48

5.35

3.2

2.6

0.7

1.75

157

1103

(3043409) Potassium [Moles/volume] in Arterial blood

122

784

1.58

5.33

4.3

3.7

mmol/l

3.8

3.9

2.04

114

735

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

101

2.69

5.33

2.2

2.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

109

682

1.62

5.32

1.6

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

191

1349

1.44

5.32

2.6

2.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.99

5.25

3.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

362

1.84

5.16

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

216

2.10

5.14

1.5

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

473

1.73

5.14

2.9

3.1

—

(1616796) Gas panel - Central venous blood

549

1.68

5.13

2.9

4.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

162

1119

1.47

5.08

4.9

6.0

1.7

1.6

0.57

156

1043

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.09

5.06

1.3

1.1

87.6

85.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

169

1178

1.46

5.06

3.3

2.7

1.4

1.2

1.53

169

1168

(3002032) Base excess in Venous blood by calculation

309

2384

1.33

5.03

4.1

3.7

mmol/l

2.1

2.0

0.15

250

1932

(3007566) Smooth muscle Ab [Titer] in Serum

108

685

1.60

5.01

1.3

1.2

titre

76.7

105.8

—

(3045716) Anion gap in Serum or Plasma

129

2.42

4.96

1.6

2.7

mmol/l

8.5

9.8

1.09

101

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

3.04

4.94

1.4

1.1

125.2

98.6

1.51

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

293

2251

1.33

4.92

3.3

2.8

ng/l

162.5

208.0

1.25

269

2048

(3014148) Varicella zoster virus Ab [Titer] in Serum

244

1.98

4.73

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

265

1.94

4.72

1.1

—

(4062490)

217

2.04

4.71

1.9

1.3

—

(3005570) Glucose [Moles/volume] in Urine

266

1.93

4.68

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

784

6794

1.20

4.66

4.5

3.7

88.9

90.1

0.66

759

6641

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

586

4936

1.23

4.66

2.7

3.2

mmol/l

2.5

1.10

530

4343

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.65

4.65

1.1

1.0

—

(40762814) Titanium [Mass/volume] in Blood

3.70

4.64

2.1

2.2

ug/l

3.0

5.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

115

2.45

4.62

1.3

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

115

2.45

4.62

1.3

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

156

1094

1.45

4.55

1.5

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

212

1569

1.38

4.55

3.8

3.2

g/l

129.9

128.8

0.27

203

1523

(3027923) C peptide [Moles/volume] in Serum or Plasma

123

2.37

4.48

1.8

1.3

nmol/l

1.2

1.1

0.21

(3044889) 12 lead EKG panel

2054

19318

1.17

4.39

4.4

3.7

—

(3010503) CD19 cells [#/volume] in Blood

176

2.11

4.38

2.5

e9/l

0.1

0.2

0.66

170

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

317

1.81

4.32

1.1

—

13.5

—

(3012501) Base excess in Blood by calculation

570

1.59

4.25

3.0

4.6

mmol/l

2.7

2.6

0.09

392

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

826

7249

1.19

4.22

1.7

1.6

mmol/l

1.4

0.30

670

6009

(44816559) Phosphatidylethanol [Mass/volume] in Blood

396

1.71

4.14

1.6

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

210

1578

1.35

4.12

1.3

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

323

1.78

4.08

1.1

g/l

1.6

1.5

0.52

287

(44790048)

287

1.82

4.06

1.5

—

(44790047)

287

1.82

4.06

1.5

—

(44790049)

287

1.82

4.06

1.5

—

(44806118)

287

1.82

4.06

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

217

1.95

4.01

1.9

1.3

g/l

7.1

7.0

0.05

151

(3024139) IgG subclass 3 [Mass/volume] in Serum

217

1.95

4.01

1.9

1.3

g/l

0.4

0.11

149

(3028192) IgG subclass 2 [Mass/volume] in Serum

217

1.95

4.01

1.9

1.3

g/l

2.7

2.8

0.13

151

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

6.44

3.98

1.0

—

(3042631) Mycobacterium sp identified in Specimen

371

1.71

3.96

2.3

3.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.48

3.96

1.1

miu/ml

1477.0

1588.3

0.18

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.82

3.95

1.1

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

164

2.08

3.91

1.5

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

153

1102

1.41

3.90

4.9

6.1

0.8

0.9

0.99

146

1026

(3037756) Immunofixation for Serum or Plasma

568

1.56

3.87

1.3

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

270

1.83

3.86

1.1

1.2

u/l

64.4

56.7

0.44

186

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

657

1.52

3.85

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

405

1.67

3.84

2.9

2.8

u/ml

845.7

975.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

221

1.91

3.82

1.6

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

221

1.91

3.82

1.6

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

221

1.91

3.82

1.6

1.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

100

667

1.51

3.80

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

105

708

1.50

3.79

1.5

1.4

ug/g

290.6

266.0

0.70

438

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

174

2.02

3.73

1.4

1.6

u/ml

16.4

20.6

—

(3010421) pH of Blood

101

678

1.50

3.73

3.9

4.6

7.4

0.58

562

(3020191) Ethanol [Moles/volume] in Serum or Plasma

181

2.00

3.73

1.3

promille

1.6

1.2

0.92

140

(3048879) Bone marrow aspiration report

2.65

3.72

1.7

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.41

3.72

1.7

2.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.41

3.72

1.7

2.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

170

1261

1.37

3.66

4.0

3.4

mmol/l

25.4

25.3

0.18

161

1223

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.38

3.64

1.7

2.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

100

674

1.50

3.63

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

131

931

1.42

3.63

2.5

2.7

u/ml

0.3

0.13

526

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

554

1.55

3.61

1.3

miu/ml

209.6

222.0

0.11

239

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

214

1651

1.32

3.55

8.7

9.3

0.7

0.36

214

1637

(40768446) Kidney Pathology biopsy report

2.40

3.55

1.3

1.7

—

(3049717) Cytology report of Urine Cyto stain

136

977

1.41

3.55

2.1

2.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

214

1656

1.31

3.48

8.7

9.1

1.4

0.15

214

1643

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

266

1.78

3.43

2.5

3.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

166

2.00

3.43

2.8

2.5

e6/l

879.5

590.2

1.43

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

194

1.92

3.43

1.8

2.3

14.2

13.9

0.02

(3020876) Protein [Mass/time] in 24 hour Urine

231

1.83

3.37

1.8

2.1

—

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

998

1.39

3.32

1.8

2.2

g/l

3.7

3.8

0.55

714

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

998

1.39

3.32

1.8

2.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

121

2.16

3.31

1.6

2.1

114.7

94.4

1.80

111

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

999

1.39

3.30

1.8

2.2

g/l

7.6

7.4

0.43

744

(3002385) Erythrocyte distribution width [Ratio]

2312

22134

1.15

3.29

23.6

16.7

13.9

13.7

6.80

2285

21601

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

608

1.49

3.27

1.1

u/ml

3.7

6.1

—

(3047181) Lactate [Moles/volume] in Blood

117

832

1.42

3.26

5.4

7.4

mmol/l

1.4

1.3

0.16

106

733

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

121

870

1.41

3.18

1.5

1.7

—

(3000492) Spirometry study

281

2282

1.25

3.15

1.6

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

124

2.11

3.13

1.6

2.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

124

2.11

3.13

1.6

2.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

124

2.11

3.13

1.6

2.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

124

2.11

3.13

1.6

2.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

932

1.39

3.13

1.9

2.3

g/l

3.0

3.1

0.54

729

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

582

1.49

3.11

1.3

mg/l

876.7

533.8

0.54

548

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

479

4111

1.19

3.11

3.5

2.7

e6/l

2.7

2.6

0.09

295

2202

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

422

1.58

3.09

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

383

1.60

3.08

2.1

2.0

u/l

6427.8

2951.1

0.45

171

(3026480) Teichoate Ab [Titer] in Serum

5.01

3.05

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

488

1.53

3.03

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.90

3.02

1.6

1.5

ng/l

94.6

133.5

0.45

(3009214) Lutropin [Units/volume] in Serum or Plasma

498

1.52

2.99

1.2

1.4

u/l

12.2

11.0

0.29

406

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

226

1.78

2.98

1.2

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.64

2.96

1.1

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.47

2.95

1.1

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

116

842

1.39

2.91

2.5

2.2

g/l

1.0

1.1

0.03

721

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

290

2387

1.24

2.89

2.7

2.3

u/l

39.9

41.3

0.08

260

2048

(3000991) Gas panel - Venous blood

266

2170

1.25

2.88

8.6

—

(3004451) EKG impression Narrative

122

2.06

2.86

1.8

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

129

2.02

2.85

1.1

iu/ml

9.0

14.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.77

2.81

1.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

224

1.75

2.77

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

8.34

2.75

1.2

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

293

1.65

2.75

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

294

1.64

2.71

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

211

1.76

2.70

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

132

1.98

2.70

2.9

2.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

635

1.43

2.68

1.7

nmol/l

38.0

42.4

1.09

616

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

193

1532

1.28

2.66

3.1

3.4

pmol/l

4.4

0.32

174

1372

(3043238) Trisomy 21 risk [Likelihood] in Fetus

233

0.38

2.65

1.1

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

154

1.89

2.65

2.3

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

273

1.66

2.65

1.3

2.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

213

1.75

2.63

2.4

39.3

40.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

190

1509

1.27

2.61

1.2

iu/ml

115.3

132.3

0.23

554

(3035637) Corticotropin [Mass/volume] in Plasma

290

1.63

2.60

1.3

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

4.67

2.59

1.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

474

1.49

2.58

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.01

2.56

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

150

1.87

2.51

1.6

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.27

2.50

1.6

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

440

1.49

2.42

1.5

1.4

u/ml

150.0

129.1

0.24

(3005033) Fetal Nuchal fold Thickness US

223

0.40

2.41

1.1

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

224

0.40

2.41

1.1

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.29

2.41

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

189

1.75

2.41

2.0

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

324

2751

1.20

2.40

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

131

1.92

2.40

1.6

1.8

u/field

4.4

1.8

0.82

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

153

1.84

2.38

1.6

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

122

927

1.33

2.36

1.9

2.2

g/l

10.1

10.3

0.17

783

(3028679) Herpes simplex virus Ab [Presence] in Serum

104

2.03

2.35

1.4

1.1

—

(3025130) Human papilloma virus identified in Specimen

292

0.44

2.35

1.5

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

153

1202

1.29

2.32

4.0

3.9

mmol/l

24.6

24.2

0.73

130

1086

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

169

1.78

2.32

1.5

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.19

2.30

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.86

2.30

1.3

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

119

1.94

2.30

1.7

2.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

414

1.48

2.27

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

692

1.37

2.24

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

149

1.82

2.24

1.0

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.11

2.22

1.4

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.11

2.22

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

5.56

2.21

1.8

2.0

—

(3016018) Differential panel - Cerebral spinal fluid

241

1.63

2.19

1.3

1.2

—

(3017704) Immunofixation for Urine

143

1.82

2.18

1.1

1.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.34

2.18

1.1

1.0

—

(44813793)

144

1.81

2.14

1.1

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

137

1.83

2.13

1.0

1.1

u/l

101.4

84.8

0.34

112

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

138

1.82

2.09

1.0

1.1

u/l

44.5

27.7

0.28

109

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.00

2.07

1.2

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

5.00

2.07

1.2

1.0

—

(3016228) CD19 cells/100 cells in Blood

124

1.86

2.06

1.7

2.3

4.7

7.9

1.57

119

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

124

1.86

2.06

1.0

1.2

ratio

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

3.50

2.05

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

221

1841

1.21

2.04

2.4

2.1

nmol/l

13.2

12.9

0.18

190

1621

(3027570) Oxalate [Moles/time] in 24 hour Urine

4.00

2.04

1.8

1.3

umol/24h

278.7

318.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

102

774

1.33

2.03

2.0

1.9

g/l

37.2

37.4

0.20

664

(3036489) Thrombin time

117

906

1.30

2.02

3.0

1.9

22.3

21.6

0.39

808

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

2.11

2.02

1.7

1.2

umol/l

4.0

3.8

0.04

(3034092) Cytoplasmic Ig cells/100 cells in Blood

3.08

2.01

10.3

9.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

732

1.33

2.01

3.7

2.3

g/l

3.6

0.11

697

(3003181) Sodium [Moles/volume] in Urine

459

1.42

2.01

1.4

1.3

mmol/l

55.4

63.0

0.73

361

(3037692) Legionella sp identified in Specimen by Organism specific culture

111

1.90

2.00

1.5

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

133

1.81

1.99

2.2

2.0

ug/min

155.6

354.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.15

1.98

1.9

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.15

1.98

1.9

2.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

639

1.35

1.97

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.73

1.93

10.6

11.0

mmol/l

4.9

6.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

120

1.84

1.92

1.1

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

158

1.71

1.88

1.3

1.8

umol/l

5.6

10.2

0.64

108

(3000330) Specific gravity of Urine by Test strip

160

1301

1.24

1.88

3.7

3.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

121

1.82

1.88

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

176

1448

1.23

1.86

9.0

11.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

129

1.79

1.85

1.1

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

2.03

1.85

1.8

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

535

1.37

1.84

3.0

nmol/l

0.7

0.8

0.60

415

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.06

1.80

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.76

1.79

1.8

1.1

—

(3039000) Anion gap in Blood

609

1.34

1.76

6.0

8.6

mmol/l

11.4

11.2

0.18

540

(3018572) Chloride [Moles/volume] in Blood

610

1.34

1.74

6.0

8.6

mmol/l

103.1

105.2

2.27

541

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

380

1.43

1.74

1.5

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

125

1.76

1.71

1.1

1.2

—

(3017569) Oxygen content in Arterial blood

125

1.76

1.71

3.8

2.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

103

1.85

1.71

28.2

31.1

ug/l

8.2

7.5

0.42

(3006922) Hepatitis E virus Ab [Presence] in Serum

163

1.66

1.71

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

631

1.32

1.68

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

111

1.81

1.68

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

267

1.50

1.68

3.0

3.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

597

1.33

1.67

2.0

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

737

1.30

1.67

2.1

g/l

0.0

0.57

674

(3003338) MCHC [Mass/volume]

2195

22594

0.91

1.67

26.0

17.5

g/l

331.1

332.2

6.75

2182

22411

(3002256) Pathology report gross observation

400

3566

1.14

1.64

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

181

1.61

1.63

1.4

1.6

u/l

6.3

5.6

0.12

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

762

7053

1.10

1.63

4.2

4.1

20.9

21.8

0.87

355

3462

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.57

1.61

3.0

2.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.15

1.61

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

182

1.60

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

698

1.30

1.60

3.5

2.8

mg/l

1.8

1.6

1.08

633

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.95

1.59

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

337

1.43

1.59

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.00

1.58

1.7

2.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.70

1.58

1.1

—

(21494755) Public health laboratory ask at order entry panel

186

2194

0.84

1.56

1.3

1.4

—

(3019977) pH of Arterial blood

145

1.66

1.54

3.9

2.8

7.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.43

1.53

1.5

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

677

1.29

1.52

5.8

2.3

182.3

197.9

0.90

647

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

168

1409

1.20

1.51

9.2

9.7

mmol/l

24.3

24.4

0.28

156

1325

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

177

1.59

1.51

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.86

1.50

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

316

1.43

1.50

1.1

118.3

115.0

0.20

283

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

419

1.37

1.47

1.4

1.2

u/ml

37.0

35.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.50

1.45

1.0

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.92

1.43

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.73

1.43

2.0

1.2

umol/24h

1.5

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

212

1.51

1.43

2.2

2.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

517

1.32

1.42

1.4

1.3

e6/l

14.4

31.4

0.61

391

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

518

1.32

1.40

1.5

1.4

e6/l

661.2

650.0

0.01

421

(3009542) Hematocrit [Volume Fraction] of Blood

2486

24310

1.09

1.40

20.0

14.7

39.7

0.01

1608

17107

(3037556) Urate [Mass/volume] in Serum or Plasma

1.86

1.40

1.5

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.08

1.38

1.1

1.2

—

(3000012) Reticulocyte production index

142

1.62

1.38

1.3

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.61

1.36

2.7

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.61

1.36

1.8

3.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

127

1.66

1.36

1.2

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

460

1.33

1.36

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.83

1.35

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

567

1.29

1.33

2.7

2.6

umol/l

28.6

34.1

2.29

481

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.10

1.30

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.10

1.30

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.10

1.30

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.36

1.29

1.4

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.76

1.28

2.1

1.3

umol/l

73.7

183.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.78

1.28

1.2

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.72

1.27

1.0

1.1

85.9

90.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

294

1.40

1.26

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

328

1.38

1.26

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

154

1.56

1.25

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

751

1.25

1.9

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

680

1.26

1.24

2.2

2.0

g/l

0.0

0.00

632

(3035320) C reactive protein [Mass/volume] in Body fluid

163

1.54

1.22

1.6

2.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

155

1.55

1.22

1.1

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

425

1.32

1.22

1.2

u/ml

238.8

283.2

0.68

263

(3019174) dRVVT (LA screen)

2.63

1.21

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.16

1.21

2.3

2.0

—

(4306422)

322

1.37

1.21

1.1

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

692

1.25

1.20

2.2

2.0

g/l

0.0

0.00

633

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

132

1.59

1.20

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

132

1.59

1.20

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

132

1.59

1.20

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

409

1.33

1.20

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

621

1.26

1.19

2.2

2.3

ug/min

108.3

108.0

0.00

384

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.31

1.18

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

109

1.65

1.18

1.4

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

125

1.60

1.17

1.5

1.2

nmol/l

137.8

135.2

0.11

125

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

632

1.26

1.17

2.8

3.4

u/ml

4413.1

974.3

0.36

573

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

133

1.58

1.17

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

133

1.58

1.17

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

133

1.58

1.17

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

265

1.40

1.16

1.2

1.5

nmol/l

0.2

0.3

1.30

204

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.05

1.15

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.50

1.15

1.8

2.1

—

(3024928) Oxygen saturation in Venous blood

518

1.28

1.14

3.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.85

1.13

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

690

1.24

1.12

1.5

—

(4015189)

1.90

1.12

5.8

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

242

1.41

1.11

3.1

mg/l

40.2

35.5

0.06

184

(3042111) Morphology [Interpretation] in Bone marrow Narrative

513

1.27

1.09

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

201

2278

0.87

1.08

1.9

1.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.19

1.08

1.3

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.87

1.07

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

391

1.31

1.07

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

145

1.52

1.05

2.8

2.6

34.0

38.6

—

(3025315) Body weight

2.27

1.03

4.6

4.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

179

1.46

1.02

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.84

1.02

1.3

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

287

0.66

1.02

1.2

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.88

1.00

3.9

3.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

326

1.32

0.99

1.2

1.3

—

(3020491) Glucose [Moles/volume] in Blood

173

1.45

0.97

1.6

2.0

mmol/l

6.8

6.7

0.06

111

(3032773) Endomysium IgG Ab [Titer] in Serum

182

1.43

0.95

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

408

1.28

0.94

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.78

0.94

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

117

1.54

0.93

5.9

3.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

269

0.67

0.93

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

269

0.67

0.93

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

269

0.67

0.93

1.3

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

1.73

0.92

1.4

2.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.82

0.92

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

268

0.67

0.92

1.3

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

2.14

0.91

1.2

1.3

—

(3003694) ABO and Rh group [Type] in Blood

758

7196

1.07

0.89

1.4

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.91

0.88

4.5

5.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

280

1.32

0.88

1.9

1.8

—

1093.3

—

(3035933) Granulocytes/100 leukocytes in Blood

1.79

0.87

1.2

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

203

1.38

0.87

1.6

1.2

—

(3006270) Folate [Moles/volume] in Blood

213

1.36

0.84

1.2

1.1

nmol/l

384.2

366.7

0.13

180

(3028433) Virus identified in Specimen by Culture

1.56

0.84

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

533

1.22

0.83

1.6

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.88

0.81

2.0

1.9

umol/l

16.8

16.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

131

1493

0.87

0.81

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

105

1.53

0.81

1.8

2.1

—

(3027008) Opiates [Presence] in Urine

535

1.22

0.81

1.6

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

176

0.62

0.79

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

482

1.23

0.79

1.7

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

628

1.20

0.79

1.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.73

0.79

1.3

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.79

0.0

1.3

—

(40768441) Liver Pathology biopsy report

190

1.37

0.78

1.3

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.78

0.0

1.0

—

22.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

547

1.21

0.78

3.1

1.7

nmol/l

1.0

0.8

0.71

464

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.62

0.78

1.7

—

(3028300) Cannabinoids [Presence] in Urine

539

1.21

0.77

1.6

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

252

1.31

0.76

2.1

2.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.77

0.76

1.7

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.70

0.75

1.0

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

1.67

0.72

1.4

—

(40757373) Influenza virus identified in Isolate

1.58

0.71

2.3

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.92

0.70

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

203

1.33

0.70

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.55

0.69

1.6

2.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.85

0.68

2.0

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

119

1.43

0.66

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.79

0.66

3.8

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.79

0.66

1.2

—

(3011288) Drugs identified in Urine by Screen method

331

1.24

0.65

5.0

2.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

103

1.46

0.65

1.1

1.0

—

(4211845)

129

1.40

0.63

5.9

3.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

216

1.30

0.63

1.7

2.1

u/field

4.1

1.7

0.63

(3028308) Erythrocytes [#/volume] in Pleural fluid

288

1.25

0.62

1.4

e6/l

32007.4

79055.0

0.94

160

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.63

0.62

1.0

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.50

0.59

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

245

1.27

0.59

1.1

1.2

—

(3011648) Oxygen content in Venous blood

183

1.31

0.59

2.0

1.9

11.7

11.8

0.02

183

(3027944) Amphetamines [Presence] in Urine

528

1.18

0.59

1.5

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

131

1.38

0.59

7.8

10.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

640

1.16

0.59

1.7

1.8

iu/l

4.3

5.0

0.24

237

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

743

1.15

0.59

3.4

2.0

88.4

90.1

0.25

698

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.56

0.58

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.56

0.58

1.3

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.58

0.0

2.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.72

0.57

1.3

2.2

—

16.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

485

0.82

0.57

1.4

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.48

0.57

1.4

3.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

429

1.19

0.56

1.2

1.3

u/l

16.8

43.8

2.67

367

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.67

0.56

1.3

1.4

—

(3008295) Osmolality of Serum or Plasma

256

1.25

0.56

1.2

1.3

mosm/kgh2o

282.0

277.9

0.38

196

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

329

1.22

0.55

1.1

1.2

u/ml

1.8

5.2

—

119

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.54

0.55

1.3

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

182

0.71

0.54

2.3

1.5

umol/l

11.6

12.9

0.54

169

(4133840)

1.48

0.53

1.8

1.1

—

(40768793) Breast Pathology biopsy report

663

0.86

0.53

1.3

—

(40758292) HTLV I+II Ab panel - Serum

1.54

0.53

1.0

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

178

1.29

0.52

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.52

0.52

1.2

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

100

0.60

0.51

2.5

2.3

nmol/l

152.0

148.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.41

0.51

1.4

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

215

1.26

0.50

1.0

1.1

u/ml

5.7

3.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

539

5168

1.05

0.49

3.1

2.9

ug/l

0.7

0.8

1.17

342

3440

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

1.40

0.48

1.3

1.1

ng/l

126.4

292.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

244

1.23

0.48

1.6

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.49

0.47

1.1

pmol/l

—

5.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.47

0.47

1.3

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

254

1.22

0.47

2.9

4.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.46

0.46

1.1

1.2

—

(4035726)

250

2655

0.94

0.44

1.4

—

(3042733) HLA Ab [Presence] in Serum

1.40

0.44

5.8

5.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

507

1.15

0.44

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

507

1.15

0.44

1.4

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

139

1.30

0.43

3.4

4.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1048

0.90

0.42

3.5

3.6

u/ml

135.7

1666.4

1.48

906

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.40

0.42

1.0

1.5

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

2.1

—

241.3

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.41

0.0

1.9

—

1.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

0.00

0.40

0.0

1.2

—

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.47

0.40

1.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.33

0.40

5.6

7.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

287

1.19

0.40

1.5

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

343

1.17

0.39

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

343

1.17

0.39

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

807

1.11

0.39

2.1

1.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.41

0.39

5.2

7.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.41

0.39

1.4

1.9

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.2

—

32.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

6.3

—

(3051651) Icteric interference index of Serum or Plasma

160

1.25

0.38

3.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

233

1.20

0.38

1.0

1.1

u/ml

2.9

3.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.39

0.38

1.2

1.1

—

(3014891) Appearance of Pleural fluid

1.39

0.38

1.6

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

401

1.15

0.38

1.9

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

355

1.16

0.37

4.0

5.1

umol/l

360.4

366.8

0.10

307

(3043410) Blood group antigens tested for on Red Blood Cells

1.39

0.36

2.9

1.6

—

(40768800) Prostate Pathology biopsy report

598

0.88

0.36

1.2

—

(3023410) Appearance of Cerebral spinal fluid

226

1.20

0.35

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.36

0.34

1.2

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.30

0.33

1.5

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

182

1.21

0.33

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.70

0.33

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

185

1748

1.06

0.32

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.28

0.32

5.8

7.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.35

0.31

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

221

1.18

0.30

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

390

3769

1.04

0.29

1.4

—

(4268621)

213

1.17

0.29

1.9

2.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

112

1.25

0.28

1.1

u/l

1.1

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.32

0.28

1.0

1.3

g/l

—

0.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

308

1.14

0.27

1.2

1.1

u/ml

3.7

3.2

0.12

125

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.27

0.27

1.1

1.3

nmol/l

79.9

129.9

—

(3023419) Bacteria identified in Sputum by Culture

337

1.13

0.27

2.6

2.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

586

1.09

0.26

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

383

0.89

0.25

1.2

1.3

—

(4027681)

114

1.23

0.25

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

105

1.24

0.24

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

1.18

0.24

1.8

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

321

1.12

0.24

1.4

e6/l

3175.5

1690.4

0.75

231

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

322

1.12

0.23

1.1

1.2

u/ml

2.8

4.0

1.12

131

(3024471) HLA-A [Type]

0.76

0.22

1.0

—

(4281824)

347

0.89

0.22

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.22

0.22

4.2

4.7

umol/l

51.6

39.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

343

1.11

0.22

1.1

u/ml

1.8

1.9

—

132

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

163

1.17

0.21

6.5

6.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

314

3046

1.03

0.21

3.8

4.3

ug/l

4.3

27.2

4.75

250

2463

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.5

—

3.7

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.5

—

3.8

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.5

—

1.7

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.5

—

3.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.5

—

0.3

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.5

—

0.2

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.5

—

0.4

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.5

—

1.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

13.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.16

0.21

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

224.7

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.20

0.0

1.4

—

(3045142) Bone marrow Pathology biopsy report

326

1.11

0.20

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

136

1.18

0.20

1.1

—

(1761868) Lipid panel - Serum or Plasma

973

9594

1.02

0.20

3.0

2.9

—

(3035880) pH of Pleural fluid

144

0.83

0.19

1.3

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

155

1.16

0.19

1.4

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.18

0.19

1.3

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.22

0.19

2.9

2.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.13

0.18

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

816

0.94

0.18

1.5

1.4

—

(4198724)

1.17

0.17

1.7

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

176

1.14

0.17

1.2

1.5

u/l

13.6

12.9

0.14

169

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.11

0.17

1.1

1.5

30.7

21.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

215

1.12

0.16

4.9

5.5

u/ml

545.4

50.5

—

(1002224) Polysomnography panel

106

1013

1.05

0.16

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

196

1.12

0.16

2.0

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.11

0.16

1.3

2.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

129

0.85

0.14

1.2

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

399

0.93

0.14

1.1

iu/ml

37.4

35.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

537

1.06

0.14

1.9

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

131

1.15

0.14

3.5

3.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

139

1345

1.03

0.13

1.6

—

(3047189) Immunofixation for 24 hour Urine

132

1.14

0.13

1.1

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

180

1.11

0.13

1.3

pmol/l

53.5

60.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

106

0.85

0.13

1.6

2.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

699

0.96

0.11

5.0

4.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

819

1.04

0.10

1.4

iu/l

30.3

33.5

0.43

703

(3050129) First trimester maternal screen panel - Serum or Plasma

321

0.93

0.10

1.5

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

331

0.94

0.10

3.0

2.3

—

(40768806) Pleura Pathology biopsy report

290

0.93

0.10

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

164

1.10

0.09

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

116

1.12

0.09

9.4

11.1

mmol/l

0.6

0.38

106

(3045683) HLA typing for celiac disease panel - Blood or Tissue

124

0.89

0.09

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.11

0.09

1.2

2.5

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.07

0.08

1.0

1.2

—

296.0

—

(3035285) Chloride [Moles/volume] in Venous blood

337

0.95

0.07

2.9

2.3

mmol/l

105.3

105.0

0.13

330

(3041354) Potassium [Moles/volume] in Venous blood

337

0.95

0.07

2.9

2.3

mmol/l

4.0

4.1

0.30

330

(3012441) Differential panel - Pleural fluid

274

1.06

0.07

1.6

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

0.85

0.07

1.1

1.4

mmol/l

3.4

3.3

—

(3022689) Creatine [Moles/volume] in Urine

1.07

0.07

1.8

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

206

1.07

0.07

1.3

1.4

g/l

0.9

1.0

1.31

206

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

132

0.91

0.06

1.1

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

132

0.91

0.06

1.1

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

572

1.03

0.06

4.2

3.3

mg/l

23.7

28.2

0.48

346

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

188

1.06

0.05

1.2

1.3

u/l

16.7

12.2

0.66

170

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.11

0.05

1.2

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

287

1.05

0.05

1.0

1.1

u/ml

0.2

1.1

—

115

(1617658) Protocol used for examination of sentinel lymph nodes

248

1.05

0.05

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

268

1.05

0.04

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

298

1.04

0.04

1.1

u/ml

1.1

5.4

3.65

134

(3036603) Volume of Urine

180

1.06

0.04

1.6

1.7

1715.2

1913.1

—

(3045788) Cell count panel - Pleural fluid

260

0.96

0.03

1.5

1.4

—

(40768795) Lymph node Pathology biopsy report

310

0.97

0.03

1.4

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

112

1.07

0.03

1.3

mmol/l

5.7

6.1

0.68

106

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

203

1.03

0.01

1.0

ng/l

598.2

690.9

0.64

136

(3001019) Free T4 and TSH panel - Serum or Plasma

120

1192

1.01

0.01

1.8

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

104

1.06

0.00

1.4

1.5

—

1337830.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

136

0.96

0.00

1.5

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

124

1.05

0.00

1.0

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

204

1.03

0.00

1.0

ng/l

399.7

355.5

0.27

141

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

306

0.98

0.00

1.4

1.2

mmol/l

7.1

7.7

0.41

221

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

336

0.98

0.00

3.3

3.8

nmol/l

4.7

22.6

0.56

328

(4094501)

754

1.01

0.00

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.04

0.00

2.3

2.0

—

(21494434) Karyotype in Bone marrow

255

1.02

0.00

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.02

0.00

1.6

1.1

—

(3004775) Volume in Urine collected for unspecified duration

211

1.00

0.00

2.0

2.2

636.7

617.5

0.08

139

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

214

0.98

0.00

1.4

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

183

0.98

0.00

1.6

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

905

1.01

0.00

1.5

1.6

mg/l

3.0

4.4

0.82

627

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

205

1.02

0.00

1.0

ng/l

58.1

46.7

0.47

139

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

326

1.01

0.00

2.0

2.1

ug/l

16.2

27.1

1.63

321

(3034426) Prothrombin time (PT)

0.96

0.00

1.0

1.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.00

0.00

2.4

1.8

iu/ml

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.85

0.00

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

2.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.7

—

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

0.93

0.00

2.8

1.9

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.96

0.00

1.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(44806420)

0.90

0.00

2.4

2.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.98

0.00

1.2

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.96

0.00

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3024932) HLA-DR beta [Type]

0.90

0.00

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SPONTRUPTSYNOTEND and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SPONTRUPTSYNOTEND	1.04 [0.93, 1.17]	0.499
Birth year	0.998 [0.99, 1.01]	0.632

During the follow-up period (1.1.1998 — 31.12.2019), 1256 out of 7895 females with M13_SPONTRUPTSYNOTEND died.

Males

Parameter	HR [95% CI]	p-value
M13_SPONTRUPTSYNOTEND	1.104 [0.98, 1.25]	0.115
Birth year	0.986 [0.98, 1.0]	0.008

During the follow-up period (1.1.1998 — 31.12.2019), 997 out of 5873 males with M13_SPONTRUPTSYNOTEND died.

Mortality risk

Mortality risk for people of age

years, who have M13_SPONTRUPTSYNOTEND.

N-year risk	Females	Males
1	0.08%	0.222%
5	0.608%	1.195%
10	1.552%	3.132%
15	3.037%	5.739%
20	5.617%	9.955%

Relationships between endpoints

↥

Index endpoint: M13_SPONTRUPTSYNOTEND – Spontaneous rupture of synovium and tendon

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Spontaneous rupture of synovium and tendon

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints